Press releases

Month Year

Email alerts

Apr 4, 2011

Medtronic Announces Mac Compatibility for CareLink(R) Personal Therapy Management Software for Diabetes

Software Helps Users Identify Low and High Glucose Levels

MINNEAPOLIS, Apr 04, 2011 (BUSINESS WIRE) -- Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval and the market launch of CareLink(R) Personal 5.4 Therapy Management...
Apr 4, 2011

Landmark IMPROVE HF Study Shows Adherence to Outpatient Quality Measures Associated with Improved Survival in Heart Failure Patients

Study Published Today in Circulation is the First to Assess the Correlation of Seven Heart Failure Process-Based Quality Measures with Clinical Outcomes

MINNEAPOLIS, Apr 04, 2011 (BUSINESS WIRE) -- Results from the largest U.S. outpatient heart failure clinical study, published today in the journal Circulation and funded by Medtronic, Inc. (NYSE:...
Apr 1, 2011

Medtronic Announces FDA Approval of InterStim(R) Therapy for Bowel Control

Unique Sacral Nerve Stimulation Therapy Now Available for Treatment of Chronic Fecal Incontinence

MINNEAPOLIS, Apr 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of InterStim(R) Therapy for Bowel Control. InterStim...
Mar 28, 2011

Medtronic to Unveil Pivotal U.S. Data on Resolute(R) Drug-Eluting Stent at ACC.11

Late-Breaking Clinical Trials Feature One-Year Results of RESOLUTE US Study; Latest Evidence from Comprehensive Research Program Completes FDA Approval Submission

MINNEAPOLIS, Mar 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced the imminent release of the pivotal U.S. data on its Resolute(R) drug-eluting stent (DES) at ACC.11, the 60th
Mar 28, 2011

Medtronic Announces FDA Approval of Protecta(TM) Implantable Defibrillators That Reduce Inappropriate Shocks

New Implantable Cardiac Devices with SmartShock(TM) Technology Enhance Patient Quality of Life

MINNEAPOLIS, Mar 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Protecta(TM)portfolio of implantable...

Show per page